1. Home
  2. COGT vs BANR Comparison

COGT vs BANR Comparison

Compare COGT & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • BANR
  • Stock Information
  • Founded
  • COGT 2014
  • BANR 1890
  • Country
  • COGT United States
  • BANR United States
  • Employees
  • COGT N/A
  • BANR N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • BANR Major Banks
  • Sector
  • COGT Health Care
  • BANR Finance
  • Exchange
  • COGT Nasdaq
  • BANR Nasdaq
  • Market Cap
  • COGT 2.3B
  • BANR 2.2B
  • IPO Year
  • COGT 2018
  • BANR 1995
  • Fundamental
  • Price
  • COGT $36.63
  • BANR $62.17
  • Analyst Decision
  • COGT Buy
  • BANR Buy
  • Analyst Count
  • COGT 13
  • BANR 5
  • Target Price
  • COGT $28.08
  • BANR $71.50
  • AVG Volume (30 Days)
  • COGT 4.8M
  • BANR 197.6K
  • Earning Date
  • COGT 11-03-2025
  • BANR 10-15-2025
  • Dividend Yield
  • COGT N/A
  • BANR 3.30%
  • EPS Growth
  • COGT N/A
  • BANR 14.84
  • EPS
  • COGT N/A
  • BANR 5.49
  • Revenue
  • COGT N/A
  • BANR $640,027,000.00
  • Revenue This Year
  • COGT N/A
  • BANR $0.69
  • Revenue Next Year
  • COGT N/A
  • BANR $7.83
  • P/E Ratio
  • COGT N/A
  • BANR $11.35
  • Revenue Growth
  • COGT N/A
  • BANR 7.86
  • 52 Week Low
  • COGT $3.72
  • BANR $54.01
  • 52 Week High
  • COGT $37.08
  • BANR $78.05
  • Technical
  • Relative Strength Index (RSI)
  • COGT 83.97
  • BANR 53.69
  • Support Level
  • COGT $32.85
  • BANR $58.50
  • Resistance Level
  • COGT $36.29
  • BANR $63.08
  • Average True Range (ATR)
  • COGT 2.62
  • BANR 1.45
  • MACD
  • COGT 1.10
  • BANR 0.15
  • Stochastic Oscillator
  • COGT 98.45
  • BANR 80.87

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

Share on Social Networks: